How environmental factors affect diabetes development in Latinos
SOLAir: Environmental Factors and Diabetes Development in Latinos
This study is looking at how things like air pollution from traffic might affect the chances of getting Type 2 diabetes in Latino communities, and it’s for people who want to understand how their environment and lifestyle choices, like what they eat and how much they move, can impact their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11161087 on NIH RePORTER |
What this research studies
This research investigates the relationship between environmental factors, particularly traffic-related air pollutants, and the risk of developing Type 2 diabetes in Latino populations. By utilizing advanced environmental exposure assessments alongside detailed health measures, the study aims to understand how these factors interact with lifestyle elements like diet and physical activity. The research focuses on a cohort from the Hispanic Community Health Study, which provides valuable longitudinal data on health and diabetes risk. Participants will be assessed for various health metrics to identify potential risk and protective factors related to diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino adults living in urban areas who may be at risk for Type 2 diabetes.
Not a fit: Patients who do not identify as Latino or those who do not live in urban environments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and prevention strategies for Type 2 diabetes in Latino communities.
How similar studies have performed: Previous studies have shown varying results regarding environmental factors and diabetes risk, indicating that this research could provide new insights into an underexplored area.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Kaufman, Joel Daniel — University of Washington
- Study coordinator: Kaufman, Joel Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.